Combined Ligand- and Receptor-Based Virtual Screening Methodology to Identify Structurally Diverse Protein Tyrosine Phosphatase 1B Inhibitors

ChemMedChem
Aleix GimenoSantiago Garcia-Vallvé

Abstract

Protein tyrosine phosphatase 1B (PTP1B) is a potential drug target for diabetes and obesity. However, the design of PTP1B inhibitors that combine potency and bioavailability is a great challenge, and new leads are needed to circumvent this problem. Virtual screening (VS) workflows can be used to find new PTP1B inhibitors with little chemical similarity to existing inhibitors. Unfortunately, previous VS workflows for the identification of PTP1B inhibitors have several limitations, such as a small number of experimentally tested compounds and the low bioactivity of those compounds. We developed a VS workflow capable of identifying 15 structurally diverse PTP1B inhibitors from 20 compounds, the bioactivity of which was tested in vitro. Moreover, we identified two PTP1B inhibitors with the highest bioactivity reported by any VS campaign (i.e., IC50 values of 1.4 and 2.1 μm), which could be used as new lead compounds.

References

Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M F CicirelliE G Krebs
Feb 1, 1995·Protein Engineering·A C WallaceJ M Thornton
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y A PuiusZ Y Zhang
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Feb 8, 2002·American Journal of Human Genetics·Rosa Di PaolaVincenzo Trischitta
Apr 24, 2002·Developmental Cell·Janice M ZabolotnyBenjamin G Neel
Apr 24, 2002·Developmental Cell·Alan ChengMichel L Tremblay
Oct 1, 2003·Biochemistry·Giovanna ScapinErnest Asante-Appiah
Dec 30, 2003·Journal of Medicinal Chemistry·Wely B FlorianoWilliam A Goddard
Jan 3, 2006·Bioorganic & Medicinal Chemistry Letters·Sean R KlopfensteinKevin G Peters
Feb 8, 2006·Journal of Molecular Endocrinology·N T LamT J Kieffer
Oct 14, 2006·Endocrinology·Christopher D MorrisonThomas W Gettys
Dec 15, 2006·Nature·Luc F Van GaalChristophe E De Block
Jul 10, 2007·Archives of Pharmacal Research·Kavitha BharathamKeun Woo Lee
Nov 27, 2007·Bioorganic & Medicinal Chemistry Letters·Brent DoutyEddy W Yue
Dec 7, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·Shlomit Koren, I George Fantus
Mar 10, 2009·European Journal of Medicinal Chemistry·Hwangseo ParkHyeongjin Cho
Mar 14, 2009·Bioorganic & Medicinal Chemistry Letters·Anil K SaxenaArvind K Srivastava
Dec 23, 2009·Vascular Pharmacology·Bonnie K Surmi, Alyssa H Hasty
Apr 23, 2010·Current Opinion in Lipidology·Emily K AndersonAlyssa H Hasty
Dec 23, 2011·Bioorganic & Medicinal Chemistry Letters·Dipam PatelPrashant Kapadnis
Apr 28, 2012·Bioinformatics·Adrià Cereto-MassaguéSantiago Garcia-Vallvé
May 17, 2012·Journal of Chemical Information and Modeling·John J IrwinRyan G Coleman
Jul 28, 2012·Annals of Medicine·Nassim Dali-YoucefEmmanuel Andrès
Nov 10, 2012·Bioinformation·Pasupuleti Sreenivasa RaoRajitha Kalashikam
Jun 12, 2013·Cell Metabolism·Marc Y DonathMarianne Böni-Schnetzler
Jul 3, 2013·Immunobiology·Victoria R RichardsonAngela M Carter
Jul 31, 2013·Journal of Cheminformatics·Adrià Cereto-MassaguéGerard Pujadas
Nov 12, 2013·Nucleic Acids Research·A Patrícia BentoJohn P Overington
Apr 18, 2014·Journal of Immunology Research·Longbiao YaoJana Barlic-Dicen
May 7, 2014·Diabetes Research and Clinical Practice·Nathalie EsserNicolas Paquot
Jul 20, 2014·Journal of Molecular Graphics & Modelling·Mohammad A GhattasRichard A Bryce
Aug 19, 2014·Methods : a Companion to Methods in Enzymology·Adrià Cereto-MassaguéGerard Pujadas
Oct 10, 2014·European Journal of Medicinal Chemistry·Vishal M BalaramnavarAnil K Saxena
Sep 7, 2016·Journal of Molecular and Cellular Cardiology·Pierre-Alain ThiebautVincent Richard
Dec 23, 2016·Journal of Molecular Graphics & Modelling·Sharat ChandraMohammad Imran Siddiqi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.